Sunesis Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference
November 11 2010 - 7:30AM
Marketwired
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) a biopharmaceutical
company focused on the development and commercialization of new
oncology therapeutics for the treatment of solid and hematologic
cancers, today announced that Daniel Swisher, Chief Executive
Officer of Sunesis, will be presenting at the Lazard Capital
Markets Annual Healthcare Conference on Tuesday, November 16, 2010
at 9:25 A.M. Eastern Time at the St. Regis Hotel in New York City.
A live webcast of this presentation will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of hematologic and solid tumor cancers. Sunesis has
built a highly experienced cancer drug development organization
committed to advancing its lead product candidate, vosaroxin, in
multiple indications to improve the lives of people with
cancer.
Investor and Media Inquiries: David Pitts Argot Partners
212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals, Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024